Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data
Clarke, Noel W
van der Meulen, J
AffiliationDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, United Kingdom;
MetadataShow full item record
AbstractBACKGROUND: Non-osteoporotic skeletal-related events (SREs) are clinically important markers of disease progression in prostate cancer. We developed and validated an approach to identify SREs in men with prostate cancer using routinely-collected data. METHODS: Patients diagnosed with prostate cancer between January 2010 and December 2013 were identified in the National Prostate Cancer Audit, based on English cancer registry data. A coding framework was developed based on diagnostic and procedure codes in linked national administrative hospital and routinely-collected radiotherapy data to identify SREs occurring before December 2015. Two coding definitions of SREs were assessed based on whether the SRE codes were paired with a bone metastasis code ('specific definition') or used in isolation ('sensitive definition'). We explored the validity of both definitions by comparing the cumulative incidence of SREs from time of diagnosis according to prostate cancer stage at diagnosis with death as a competing risk. RESULTS: We identified 40,063, 25,234 and 13,968 patients diagnosed with localised, locally advanced and metastatic disease, respectively. Using the specific definition, we found that the 5-year cumulative incidence of SREs was 1.0 % in patients with localised disease, 6.0 % in patients with locally advanced disease, and 42.3 % in patients with metastatic disease. Using the sensitive definition, the corresponding cumulative incidence figures were 9.0 %, 14.9 %, and 44.4 %, respectively. CONCLUSION: The comparison of the cumulative incidence of SREs identified in routinely collected hospital data, based on a specific coding definition in patients diagnosed with different prostate cancer stage, supports their validity as a clinically important marker of cancer progression.
CitationParry MG, Cowling TE, Sujenthiran A, Nossiter J, Berry B, Cathcart P, et al. Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data. Cancer Epidemiol. 2019;63:101628.
- Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.
- Authors: Aly A, Onukwugha E, Woods C, Mullins CD, Kwok Y, Qian Y, Arellano J, Balakumaran A, Hussain A
- Issue date: 2015 Aug 19
- The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
- Authors: Jayasekera J, Onukwugha E, Bikov K, Mullins CD, Seal B, Hussain A
- Issue date: 2014 Feb
- Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
- Authors: Hussain A, Aly A, Daniel Mullins C, Qian Y, Arellano J, Onukwugha E
- Issue date: 2016 Nov
- Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
- Authors: Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT
- Issue date: 2011 Jan 24
- Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
- Authors: Barlev A, Song X, Ivanov B, Setty V, Chung K
- Issue date: 2010 Nov-Dec